For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.

Gene expression profiling in chronic inflammatory demyelinating polyneuropathy.

TitleGene expression profiling in chronic inflammatory demyelinating polyneuropathy.
Publication TypeJournal Article
Year of Publication2005
AuthorsRenaud S, Hays AP, Brannagan TH, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N
JournalJ Neuroimmunol
Volume159
Issue1-2
Pagination203-14
Date Published2005 Feb
ISSN0165-5728
KeywordsAdult, Aged, Chronic Disease, Demyelinating Diseases, Female, Gene Expression Profiling, Humans, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, Polyneuropathies, Reverse Transcriptase Polymerase Chain Reaction, Signal Transduction, Sural Nerve, Up-Regulation
Abstract

Gene expression in archived frozen sural nerve biopsies of patients with chronic inflammatory demyelinating polyneuropathy (CIDP) was compared to that in vasculitic nerve biopsies (VAS) and to normal nerve (NN) by DNA microarray technology. Hierarchical clustering analysis demonstrated distinct gene expression patterns distinguishing these disease groups. Of particular interest were: (1) Tachykinin precursor 1, which may be involved in pain mediation; (2) Stearoyl-CoA-desaturase, which may be a marker for remyelination and (3) the Allograft Inflammatory Factor 1 (AIF-1), a modulator of immune response during macrophage activation. Differential gene expression may help distinguish between CIDP, VAS and NN in sural nerve biopsies and identify genes that may be involved in disease pathogenesis.

DOI10.1016/j.jneuroim.2004.10.021
Alternate JournalJ. Neuroimmunol.
PubMed ID15652421

Weill Cornell Medicine Microbiology and Immunology 1300 York Avenue, Box 62 New York, NY 10065 Phone: (212) 746-6505 Fax: (212) 746-8587